HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiannan Kang Selected Research

Anorexia

12/2018Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiannan Kang Research Topics

Disease

5Autistic Disorder (Autism)
01/2023 - 01/2018
2Autism Spectrum Disorder
12/2022 - 01/2018
2Consciousness Disorders
01/2017 - 01/2016
1Intellectual Disability (Idiocy)
01/2022
1Cachexia
12/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2018
1Anorexia
12/2018
1Melanoma (Melanoma, Malignant)
12/2018
1Neoplasms (Cancer)
12/2018
1Brain Diseases (Brain Disorder)
01/2018
1Coma (Comas)
01/2016
1Persistent Vegetative State (Vegetative State)
01/2016

Drug/Important Bio-Agent (IBA)

1salicylhydroxamic acid (SHAM)IBA
01/2023
1Docetaxel (Taxotere)FDA Link
12/2018
1pembrolizumabIBA
12/2018
1tetraethylpyrazine (TEP)IBA
01/2016

Therapy/Procedure

4Transcranial Direct Current Stimulation
01/2023 - 01/2017
4Transcranial Magnetic Stimulation
12/2022 - 01/2016